ARF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.592400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.967000E-01
Normal-vs-Stage2
7.538800E-01
Normal-vs-Stage3
1.899970E-01
Normal-vs-Stage4
9.938800E-01
Stage1-vs-Stage2
1.822240E-01
Stage1-vs-Stage3
6.448300E-02
Stage1-vs-Stage4
5.465400E-01
Stage2-vs-Stage3
1.141050E-01
Stage2-vs-Stage4
7.110600E-01
Stage3-vs-Stage4
1.318220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.540600E-01
Normal-vs-AfricanAmerican
8.608000E-01
Normal-vs-Asian
6.233200E-01
Caucasian-vs-AfricanAmerican
5.764200E-01
Caucasian-vs-Asian
4.517200E-01
AfricanAmerican-vs-Asian
4.099200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.347600E-01
Normal-vs-Female
7.535200E-01
Male-vs-Female
4.083800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.001000E-01
Normal-vs-Age(41-60Yrs)
5.930800E-01
Normal-vs-Age(61-80Yrs)
5.811400E-01
Normal-vs-Age(81-100Yrs)
2.951800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.963000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.027440E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.489900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.575290E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.576200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.997800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.225000E-01
Normal-vs-Daily Drinker
7.417400E-01
Normal-vs-Weekly Drinker
5.550400E-01
Normal-vs-Occasional Drinker
6.376000E-01
Normal-vs-Social Drinker
8.965600E-01
Non Drinker-vs-Daily Drinker
4.158600E-01
Non Drinker-vs-Weekly Drinker
7.298400E-01
Non Drinker-vs-Occasional Drinker
1.373630E-02
Non Drinker-vs-Social Drinker
9.268300E-02
Daily Drinker-vs-Weekly Drinker
7.199800E-01
Daily Drinker-vs-Occasional Drinker
1.281620E-01
Daily Drinker-vs-Social Drinker
4.071200E-01
Weekly Drinker-vs-Occasional Drinker
8.324200E-02
Weekly Drinker-vs-Social Drinker
2.600600E-01
Occasional Drinker-vs-Social Drinker
5.325400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.431650E-01
Normal-vs-Grade 2
4.400000E-02
Normal-vs-Grade 3
4.601800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.335600E-01
Grade 1-vs-Grade 3
6.242600E-01
Grade 1-vs-Grade 4
1.431650E-01
Grade 2-vs-Grade 3
6.089600E-01
Grade 2-vs-Grade 4
4.400000E-02
Grade 3-vs-Grade 4
4.601800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.527200E-01
Normal-vs-NonDiabetic
8.845400E-01
Diabetic-vs-NonDiabetic
3.679200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.876000E-01
Normal-vs-NoPancreatitis
8.471200E-01
Pancreatitis-vs-NoPancreatitis
9.907400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.849200E-01
Normal-vs-N1
7.874800E-01
N0-vs-N1
7.175600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.126400E-01
Normal-vs-TP53-NonMutant
9.751400E-01
TP53-Mutant-vs-TP53-NonMutant
8.267800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
